Abstract
New quinolonyl diketo acid compounds bearing various substituents at position 6 of the quinolone scaffold were designed and synthesized as potential HIV-1 integrase inhibitors. These new compounds were evaluated for their antiviral and anti-integrase activity and showed inhibitory potency similar to that of 6-bromide analog 2. Molecular modeling and docking studies were performed to rationalize these data and to provide a detailed understanding of the mechanism of inhibition for this class of compounds.
Original language | English |
---|---|
Pages (from-to) | 1749-1756 |
Number of pages | 8 |
Journal | European Journal of Medicinal Chemistry |
Volume | 46 |
Issue number | 5 |
DOIs | |
Publication status | Published - 1 May 2011 |
Keywords
- Anti-integrase activity
- Antiviral activity
- Docking
- HIV-1 IN
- Molecular modeling
- Quinolonyl diketo acid